Hepatitis B Titers for Healthcare Workers: Testing, Documentation, and Non-Responders

If you run an employee health program, you've had this conversation more than once: a new nurse finishes her hepatitis B series, her titer comes back at 6 mIU/mL, and now HR wants to know whether she's "cleared" to work. The short answer is no — but the longer answer depends on which framework you're standing in.

Two separate authorities govern hepatitis B for healthcare personnel, and conflating them is the most common mistake I see. OSHA tells you what the employer is legally required to offer. CDC/ACIP tells you what the clinician should actually do. Keep those lanes straight and everything downstream — titers, revaccination, documentation — gets simpler.

The OSHA layer: what you must offer

Under the Bloodborne Pathogens Standard, employers must make hepatitis B vaccination available to every employee with occupational exposure, at no cost, after the employee has completed training and within 10 working days of initial assignment — unless the worker already completed the series, antibody testing has shown immunity, or the vaccine is contraindicated (29 CFR 1910.1030(f)(2)(i)). The vaccination, any post-exposure evaluation, and all related lab tests must be free to the employee and performed by or under a licensed healthcare professional (1910.1030(f)(1)(ii)).

OSHA stops short of one thing people routinely assume it covers: it does not require routine post-vaccination titers or periodic serologic monitoring. In a 2005 interpretation letter, OSHA stated plainly that periodic serologic testing to monitor antibody concentrations after the three-dose series is not recommended, and that neither a booster nor a new series is required unless the U.S. Public Health Service recommends one (OSHA Standard Interpretation, Nov 9, 2005). If a routine booster is ever recommended by the USPHS, the employer must then make it available at no cost (1910.1030(f)(2)(v)).

So the titer requirement doesn't come from OSHA at all. It comes from CDC.

When is a titer required?

CDC/ACIP recommends post-vaccination serologic testing (PVST) — an anti-HBs titer — for healthcare personnel at risk of percutaneous or mucosal exposure to blood or body fluids. Draw it 1 to 2 months after the final dose of the vaccine series (CDC — Responding to HBV Exposures in Health Care Settings).

Timing matters. Draw too early and you may catch a titer still climbing; draw years later and a declining number tells you nothing useful about the original response, because immune memory persists even as measurable antibody fades. The 1–2 month window is the one that documents whether the vaccine actually took.

Note the distinction from post-exposure testing. When a worker sustains a needlestick or splash, OSHA's post-exposure provisions kick in — source and employee blood collection and testing become part of the evaluation. That's a separate obligation from the routine PVST described here. Don't let a "we don't do routine titers" policy bleed into skipping exposure workups.

What titer level shows immunity?

A result of anti-HBs ≥10 mIU/mL, measured 1–2 months after the last dose, indicates immunity. That person is a responder and needs no further vaccination or testing. Use a quantitative assay that actually detects the protective concentration (CDC). Anything under 10 mIU/mL at that point is a non-response — not "low immunity," not "borderline." Below the line is below the line.

What happens with a non-responder?

This is where a clear protocol saves you from ad-hoc decisions. A worker whose anti-HBs is <10 mIU/mL after the primary series is an initial non-responder, and the pathway is well defined:

1. Complete a second three-dose series (or, before revaccinating, test for HBsAg to rule out existing chronic infection).
2. Retest anti-HBs 1–2 months after the final dose of the second series.
3. If still <10 mIU/mL, test for HBsAg (and anti-HBc) — existing hepatitis B infection is a common reason for apparent non-response, and you don't want to keep vaccinating someone who is actually chronically infected (CDC).

The encouraging news for step 1: people who don't respond to the first series have a 30%–50% chance of responding to a second (CDC MMWR 2013;62(RR-10)). So most "non-responders" convert on the second attempt.

A true non-responder is someone with anti-HBs <10 mIU/mL after six or more total doses (CDC). If that worker is HBsAg-negative, treat them as susceptible. They keep working — non-response is not a job disqualifier — but they must be flagged so that after any known or probable HBsAg-positive exposure they receive HBIG prophylaxis. That flag is only useful if it's documented somewhere your after-hours exposure responder will actually see it.

The full clinical algorithm lives in CDC MMWR 2013;62(RR-10), the controlling guidance for evaluating HCP for HBV protection. Have it on hand.

Which vaccine series? A quick reference

• Recombinant three-dose series (Engerix-B, Recombivax HB): the traditional schedule at 0, 1, and 6 months.
• Heplisav-B (HepB-CpG): a two-dose series at 0 and 1 month for adults 18 and older, FDA-approved November 9, 2017 and ACIP-recommended February 21, 2018 (CDC ACIP — GRADE: HEPLISAV-B).

Heplisav-B's compressed schedule is a real advantage for onboarding — you can complete the series in a month instead of six, then draw PVST 1–2 months out.

Documentation: the part that survives an audit

Whatever the clinical outcome, the record is what protects the organization. Capture the vaccine doses with dates, the anti-HBs result with its draw date, and the interpretation (responder, revaccinated, or documented non-responder). A worker with a completed series and a protective titer needs no revaccination — but only if you can prove it.

OSHA requires employee medical records to be retained for the duration of employment plus 30 years (1910.1030(h)(1)(iv)). And for anyone who declines vaccination, get the mandatory Appendix A declination statement signed (1910.1030(f)(2)(iv)) — a decliner who later wants the vaccine is still entitled to it at no charge.

The penalties for getting this wrong aren't trivial. OSHA's civil penalties run to tens of thousands of dollars per violation — the highest tiers apply to willful or repeated citations — and the maximums are adjusted for inflation each year (OSHA — Penalties). Missing declination forms and unretrievable titer records are exactly the kind of paperwork gap that turns a routine inspection into a citation.

Keeping doses, titers, revaccination steps, and declination forms linked to each employee — and retrievable 30 years out — is the tracking a purpose-built occupational health system is meant to hold, so the immunity picture is at hand when an exposure happens at 2 a.m.

FAQ

Does OSHA require a hepatitis B titer? No. OSHA requires the vaccine to be offered free and post-exposure testing when an incident occurs, but it does not mandate routine post-vaccination titers (OSHA, 2005). The titer recommendation comes from CDC/ACIP as clinical best practice.

What if a worker declines the titer but got the vaccine? The vaccine is what OSHA requires; PVST is a CDC recommendation. Document the completed series and the worker's choice. Without a protective titer on file, you can't classify them as a confirmed responder, which matters for post-exposure decisions.

How long do we keep these records? Duration of employment plus 30 years, per 29 CFR 1910.1030(h)(1)(iv).

Get the two frameworks straight — OSHA for the offer, CDC for the clinical protocol — and hepatitis B management stops being a source of arguments with HR. If your titer results, revaccination steps, and declination forms live in three different places, that's worth fixing before your next exposure event, not after.